These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30859183)

  • 1. Characterization and functional analysis of novel circulating NK cell sub-populations.
    Khummuang S; Chuensirikulchai K; Pata S; Laopajon W; Chruewkamlow N; Mahasongkram K; Sugiura N; Watanabe H; Tateno H; Kamuthachad L; Wongratanacheewin S; Takheaw N; Kasinrerk W
    Int Immunol; 2019 Jul; 31(8):515-530. PubMed ID: 30859183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of different functions of CD8
    Chuensirikulchai K; Pata S; Laopajon W; Takheaw N; Kotemul K; Jindaphun K; Khummuang S; Kasinrerk W
    Immunology; 2024 Jun; ():. PubMed ID: 38922845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.
    Yu MH; Roffler SR; Hwang WS; Tung E; Chen WL; Yeh MY
    Gynecol Oncol; 1992 Oct; 47(1):93-101. PubMed ID: 1427409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a human cervical carcinoma-associated antigen by lectin binding and immuno-electron microscopy.
    Wang JJ; Roffler SR; Yu MH; Yin CS; Yeh MY
    Histochemistry; 1992 Jul; 97(6):453-61. PubMed ID: 1429005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
    Chambers WH; Vujanovic NL; DeLeo AB; Olszowy MW; Herberman RB; Hiserodt JC
    J Exp Med; 1989 Apr; 169(4):1373-89. PubMed ID: 2466943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood.
    Tanaka H; Kai S; Yamaguchi M; Misawa M; Fujimori Y; Yamamoto M; Hara H
    Eur J Haematol; 2003 Jul; 71(1):29-38. PubMed ID: 12801296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
    Masuyama J; Murakami T; Iwamoto S; Fujita S
    Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody (RH1-38) which inhibits multiple systems of cell-mediated cytotoxicity--II. Evidence that the epitope recognized is involved in a late step in the cytolytic mechanism.
    Hall RE; Schall RP; Black LA
    Mol Immunol; 1985 Jul; 22(7):765-73. PubMed ID: 2412111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery.
    Moretta A; Bottino C; Tripodi G; Vitale M; Pende D; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Millo R
    Int J Cancer Suppl; 1992; 7():6-10. PubMed ID: 1428407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.
    Vivier E; Sorrell JM; Ackerly M; Robertson MJ; Rasmussen RA; Levine H; Anderson P
    J Exp Med; 1993 Dec; 178(6):2023-33. PubMed ID: 7504054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
    Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells.
    Corral L; Takizawa H; Hanke T; Jamieson AM; Raulet DH
    Hybridoma; 1999 Aug; 18(4):359-66. PubMed ID: 10571266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of NK-target cell interaction by a monoclonal antibody to K562 cells.
    Yoon SR; Cho DH; Pyun KH; Choi I
    Immunol Lett; 1998 Apr; 61(2-3):145-9. PubMed ID: 9657267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of natural killer cells by the mAb YTA-1 that recognizes leukocyte function-associated antigen-1.
    Sugie K; Nakamura K; Teshigawara K; Diamond MS; Springer TA; Nakamura Y; Leonard WJ; Uchida A; Yodoi J
    Int Immunol; 1995 May; 7(5):763-9. PubMed ID: 7547703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural cell-mediated cytotoxicity (NCMC) against NK-sensitive tumours in vitro by murine spleen Ly-6C+ natural T cells.
    Martiniello R; Burton RC; Smart YC
    Int J Cancer; 1997 Feb; 70(4):450-60. PubMed ID: 9033654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.